SlideShare a Scribd company logo
1 of 1
Download to read offline
OUR FOCUS IS ON FINDING A CURE
OR CONTROL FOR CYSTIC FIBROSIS.
Cystic Fibrosis Canada's mission is to help people with cystic fibrosis.
We fund research towards the goal of a cure or control for cystic
fibrosis, support high quality CF care, promote public awareness of
cystic fibrosis, and raise and allocate funds for these purposes.
4,000
CANADIANS WITH
CYSTIC FIBROSIS (CF)          
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
WHERE DONOR DOLLARS GO:
RESEARCH
More than $5 million awarded to 48
research projects, 27 fellows and
students and 8 special research
initiatives and partnerships
CLINICAL CARE
More than $2.2 million to 42 CF clinics
and associated outreach centres;
transplant programs; the Quality
Improvement Learning and Leadership
Collaborative (LLC) and the Canadian
CF Registry
ADVOCACY
KALYDECO® for the G551D mutation is
now available in 7 provinces and 1
territory: British Columbia, Alberta,
Saskatchewan, Manitoba, Ontario, New
Brunswick, Nova Scotia, and Yukon
Cystic Fibrosis Canada continues to
advocate for newborn screening in
Quebec, the only province left to
commit to newborn screening for CF
MORE THAN
$9.9 MILLION
INVESTED IN OUR MISSION IN 2014-2015
NEARLY 90,000 DONORS
GIVE GENEROUSLY TO VITAL
CF RESEARCH AND CARE
WE HELP FUND
42 CF CLINICS
ACROSS CANADA

40.4%

59.6%
of CF patients are childrenof CF patients are adults
IN 2013, THE PREDICTED MEDIAN
AGE OF SURVIVAL WAS 50.9 YEARS
FOR CANADIAN CF PATIENTS
CF PATIENTS SPENT A COMBINED TOTAL OF
24,619 DAYS IN THE
HOSPITAL LAST YEAR
JOIN US IN WORKING TOGETHER TOWARDS OUR
VISION FOR A WORLD WHERE CYSTIC FIBROSIS IS
NO LONGER A PROGRESSIVE LIFE-SHORTENING
DISEASE AT WWW.CYSTICFIBROSIS.CA.
CHARITABLE REGISTRATION: 10684 5100 RR0001
TELEPHONE: 1-800-378-2233
ON AVERAGE THIS IS THE EQUIVALENT OF FOUR MONTHS OF
FULL-TIME WORK DOING LIFE-SUSTAINING TREATMENTS EVERY YEAR

..........................................................................................................
..........................................................................................................

65%Chapter
12% Major Gifts
9% Kin Canada
6% Shinerama
4% Bequests
4% Royalties/Other
74% Programs 43% Research
23% Clinical Care & Advocacy
8% Education & Public Awareness
15% Administration
4% Volunteer
Support
7% Indirect
Fundraising Costs
*Net of direct fundraising costs
**Excludes direct fundraising costs
SOURCE OF FUNDS*
USE OF FUNDS**

More Related Content

Similar to 2014 annual report infographic

Snapshot introduction to our chapter 2011
Snapshot introduction to our chapter 2011Snapshot introduction to our chapter 2011
Snapshot introduction to our chapter 2011Mike Brennan
 
Snapshot Introduction To Our Chapter 2011
Snapshot Introduction To Our Chapter 2011Snapshot Introduction To Our Chapter 2011
Snapshot Introduction To Our Chapter 2011Mike Brennan
 
An introduction to our chapter 2010
An introduction to our chapter 2010An introduction to our chapter 2010
An introduction to our chapter 2010Mike Brennan
 
Board orientation 2010
Board orientation 2010Board orientation 2010
Board orientation 2010Mike Brennan
 
BTFCImpactReport2014-final
BTFCImpactReport2014-finalBTFCImpactReport2014-final
BTFCImpactReport2014-finalMegan Winkler
 
CCA-2015_AR_Final
CCA-2015_AR_FinalCCA-2015_AR_Final
CCA-2015_AR_FinalKatie Hill
 
Who We Are What We Do
Who We Are What We DoWho We Are What We Do
Who We Are What We DoDeanna Wilson
 
wpcc-directory-october-2016
wpcc-directory-october-2016wpcc-directory-october-2016
wpcc-directory-october-2016Chris Conley
 
The smiling assassin ics case study_welingkar institute of management
The smiling assassin ics case study_welingkar institute of managementThe smiling assassin ics case study_welingkar institute of management
The smiling assassin ics case study_welingkar institute of managementSwagat mishra
 
Nwe grant proposal 2013..
Nwe grant proposal 2013..Nwe grant proposal 2013..
Nwe grant proposal 2013..Ginny Dieruf
 
National breast cancer foundation
National breast cancer foundationNational breast cancer foundation
National breast cancer foundationKristina O'Sullivan
 
Cancer Support VI 2-22-2015 v2
Cancer Support VI 2-22-2015 v2Cancer Support VI 2-22-2015 v2
Cancer Support VI 2-22-2015 v2Charlene Kehoe
 
2015 Media Kit (FINAL)
2015 Media Kit (FINAL)2015 Media Kit (FINAL)
2015 Media Kit (FINAL)Stephen Ng
 
Fight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are PresentationFight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are PresentationFight Colorectal Cancer
 
CareBOX Program: Improving Cancer Care Together
CareBOX Program: Improving Cancer Care TogetherCareBOX Program: Improving Cancer Care Together
CareBOX Program: Improving Cancer Care TogetherJillian Domingue
 
March 2013 webinar congressional advocacy prep
March 2013 webinar congressional advocacy prepMarch 2013 webinar congressional advocacy prep
March 2013 webinar congressional advocacy prepFight Colorectal Cancer
 
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...linda brown
 

Similar to 2014 annual report infographic (20)

Snapshot introduction to our chapter 2011
Snapshot introduction to our chapter 2011Snapshot introduction to our chapter 2011
Snapshot introduction to our chapter 2011
 
Snapshot Introduction To Our Chapter 2011
Snapshot Introduction To Our Chapter 2011Snapshot Introduction To Our Chapter 2011
Snapshot Introduction To Our Chapter 2011
 
An introduction to our chapter 2010
An introduction to our chapter 2010An introduction to our chapter 2010
An introduction to our chapter 2010
 
Board orientation 2010
Board orientation 2010Board orientation 2010
Board orientation 2010
 
BTFCImpactReport2014-final
BTFCImpactReport2014-finalBTFCImpactReport2014-final
BTFCImpactReport2014-final
 
CCA-2015_AR_Final
CCA-2015_AR_FinalCCA-2015_AR_Final
CCA-2015_AR_Final
 
Who We Are What We Do
Who We Are What We DoWho We Are What We Do
Who We Are What We Do
 
wpcc-directory-october-2016
wpcc-directory-october-2016wpcc-directory-october-2016
wpcc-directory-october-2016
 
Summer_Issue_2015_web-2
Summer_Issue_2015_web-2Summer_Issue_2015_web-2
Summer_Issue_2015_web-2
 
The smiling assassin ics case study_welingkar institute of management
The smiling assassin ics case study_welingkar institute of managementThe smiling assassin ics case study_welingkar institute of management
The smiling assassin ics case study_welingkar institute of management
 
Nwe grant proposal 2013..
Nwe grant proposal 2013..Nwe grant proposal 2013..
Nwe grant proposal 2013..
 
National breast cancer foundation
National breast cancer foundationNational breast cancer foundation
National breast cancer foundation
 
Cancer Support VI 2-22-2015 v2
Cancer Support VI 2-22-2015 v2Cancer Support VI 2-22-2015 v2
Cancer Support VI 2-22-2015 v2
 
Cruk
CrukCruk
Cruk
 
2015 Media Kit (FINAL)
2015 Media Kit (FINAL)2015 Media Kit (FINAL)
2015 Media Kit (FINAL)
 
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
 
Fight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are PresentationFight Colorectal Cancer Who We Are Presentation
Fight Colorectal Cancer Who We Are Presentation
 
CareBOX Program: Improving Cancer Care Together
CareBOX Program: Improving Cancer Care TogetherCareBOX Program: Improving Cancer Care Together
CareBOX Program: Improving Cancer Care Together
 
March 2013 webinar congressional advocacy prep
March 2013 webinar congressional advocacy prepMarch 2013 webinar congressional advocacy prep
March 2013 webinar congressional advocacy prep
 
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
Elevate Leads the Way for a Better Cancer Survivorship Experience For Survivo...
 

2014 annual report infographic

  • 1. OUR FOCUS IS ON FINDING A CURE OR CONTROL FOR CYSTIC FIBROSIS. Cystic Fibrosis Canada's mission is to help people with cystic fibrosis. We fund research towards the goal of a cure or control for cystic fibrosis, support high quality CF care, promote public awareness of cystic fibrosis, and raise and allocate funds for these purposes. 4,000 CANADIANS WITH CYSTIC FIBROSIS (CF)           . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . WHERE DONOR DOLLARS GO: RESEARCH More than $5 million awarded to 48 research projects, 27 fellows and students and 8 special research initiatives and partnerships CLINICAL CARE More than $2.2 million to 42 CF clinics and associated outreach centres; transplant programs; the Quality Improvement Learning and Leadership Collaborative (LLC) and the Canadian CF Registry ADVOCACY KALYDECO® for the G551D mutation is now available in 7 provinces and 1 territory: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, and Yukon Cystic Fibrosis Canada continues to advocate for newborn screening in Quebec, the only province left to commit to newborn screening for CF MORE THAN $9.9 MILLION INVESTED IN OUR MISSION IN 2014-2015 NEARLY 90,000 DONORS GIVE GENEROUSLY TO VITAL CF RESEARCH AND CARE WE HELP FUND 42 CF CLINICS ACROSS CANADA  40.4%  59.6% of CF patients are childrenof CF patients are adults IN 2013, THE PREDICTED MEDIAN AGE OF SURVIVAL WAS 50.9 YEARS FOR CANADIAN CF PATIENTS CF PATIENTS SPENT A COMBINED TOTAL OF 24,619 DAYS IN THE HOSPITAL LAST YEAR JOIN US IN WORKING TOGETHER TOWARDS OUR VISION FOR A WORLD WHERE CYSTIC FIBROSIS IS NO LONGER A PROGRESSIVE LIFE-SHORTENING DISEASE AT WWW.CYSTICFIBROSIS.CA. CHARITABLE REGISTRATION: 10684 5100 RR0001 TELEPHONE: 1-800-378-2233 ON AVERAGE THIS IS THE EQUIVALENT OF FOUR MONTHS OF FULL-TIME WORK DOING LIFE-SUSTAINING TREATMENTS EVERY YEAR  .......................................................................................................... ..........................................................................................................  65%Chapter 12% Major Gifts 9% Kin Canada 6% Shinerama 4% Bequests 4% Royalties/Other 74% Programs 43% Research 23% Clinical Care & Advocacy 8% Education & Public Awareness 15% Administration 4% Volunteer Support 7% Indirect Fundraising Costs *Net of direct fundraising costs **Excludes direct fundraising costs SOURCE OF FUNDS* USE OF FUNDS**